Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9530168rdf:typepubmed:Citationlld:pubmed
pubmed-article:9530168lifeskim:mentionsumls-concept:C0024109lld:lifeskim
pubmed-article:9530168lifeskim:mentionsumls-concept:C0033085lld:lifeskim
pubmed-article:9530168lifeskim:mentionsumls-concept:C0014257lld:lifeskim
pubmed-article:9530168lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:9530168lifeskim:mentionsumls-concept:C2709248lld:lifeskim
pubmed-article:9530168lifeskim:mentionsumls-concept:C0003765lld:lifeskim
pubmed-article:9530168lifeskim:mentionsumls-concept:C0014264lld:lifeskim
pubmed-article:9530168lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:9530168lifeskim:mentionsumls-concept:C1292733lld:lifeskim
pubmed-article:9530168pubmed:issue3 Pt 1lld:pubmed
pubmed-article:9530168pubmed:dateCreated1998-4-24lld:pubmed
pubmed-article:9530168pubmed:abstractTextL-Arginine supplementation has been shown to restore endothelium-derived nitric oxide production in several pathological states. The purpose of this study was to examine the effect of administration of exogenous L-arginine on the endotoxin-induced lung neutrophil accumulation and impairment of endothelium-dependent guanosine 3',5'-cyclic monophosphate (cGMP)-mediated pulmonary vasorelaxation in rats. Endothelium-dependent relaxation was tested by receptor-dependent [acetylcholine (ACh)] and receptor-independent (A-23187) pathways. Endothelium-independent relaxation was tested with sodium nitroprusside (SNP). In isolated pulmonary arterial rings, concentration-response curves were generated with ACh, A-23187, and SNP (10(-9) to 10(-6) M) 4 h after endotoxin (500 micrograms/kg i.p.) with and without prior administration of L-arginine (300 mg/kg i.p.). Lung neutrophil accumulation was determined by myeloperoxidase (MPO) assay. After endotoxin, lung neutrophil accumulation was significantly increased (MPO activity, 3.8 +/- 0.4 vs. 0.8 +/- 0.1 units/g lung weight in control cells; P < 0.05), which was prevented by L-arginine treatment (MPO activity, 1.3 +/- 0.3 units/g lung weight; P < 0.05 vs. endotoxin). Endotoxin produced a significant impairment of endothelium-dependent cGMP-mediated pulmonary vasorelaxation by receptor-dependent (ACh) and -independent (A-23187) pathways as well as of endothelium-independent relaxation (SNP). Prior treatment with L-arginine, but not with D-arginine, preserved endothelium-dependent vasorelaxation. Neither L- nor D-arginine influenced endotoxin-induced impairment of endothelium-independent, cGMP-mediated pulmonary vasorelaxation. We conclude that administration of exogenous L-arginine prevents endotoxin-induced lung neutrophil accumulation and attenuates its associated impairment of endothelium-dependent, cGMP-mediated pulmonary vasorelaxation.lld:pubmed
pubmed-article:9530168pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:languageenglld:pubmed
pubmed-article:9530168pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:citationSubsetIMlld:pubmed
pubmed-article:9530168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9530168pubmed:statusMEDLINElld:pubmed
pubmed-article:9530168pubmed:monthMarlld:pubmed
pubmed-article:9530168pubmed:issn0002-9513lld:pubmed
pubmed-article:9530168pubmed:authorpubmed-author:MeldrumD RDRlld:pubmed
pubmed-article:9530168pubmed:authorpubmed-author:FullertonD...lld:pubmed
pubmed-article:9530168pubmed:authorpubmed-author:McIntyreR...lld:pubmed
pubmed-article:9530168pubmed:authorpubmed-author:SheridanB CBClld:pubmed
pubmed-article:9530168pubmed:issnTypePrintlld:pubmed
pubmed-article:9530168pubmed:volume274lld:pubmed
pubmed-article:9530168pubmed:ownerNLMlld:pubmed
pubmed-article:9530168pubmed:authorsCompleteYlld:pubmed
pubmed-article:9530168pubmed:paginationL337-42lld:pubmed
pubmed-article:9530168pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:meshHeadingpubmed-meshheading:9530168-...lld:pubmed
pubmed-article:9530168pubmed:year1998lld:pubmed
pubmed-article:9530168pubmed:articleTitleL-arginine prevents lung neutrophil accumulation and preserves pulmonary endothelial function after endotoxin.lld:pubmed
pubmed-article:9530168pubmed:affiliationDepartment of Surgery, University of Colorado, Denver 80262, USA.lld:pubmed
pubmed-article:9530168pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9530168pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9530168pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9530168lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9530168lld:pubmed